Comparison of Ischemic and Bleeding Events After Drug-Eluting Stents or Bare Metal Stents in Subjects Receiving Dual Antiplatelet Therapy: Results from the Randomized Dual Antiplatelet Therapy Study

被引：0

作者：

Kereiakes, Dean J. ^{[1
]}

Yeh, Robert J. ^{[2
]}

Massaro, Joseph M. ^{[3
]}

Driscoll-Shempp, Priscilla ^{[4
]}

Cutlip, Donald E. ^{[5
]}

Normand, Sharon-Lise T. ^{[6
]}

Steg, Philippe G. ^{[7
]}

Gershlick, Anthony H. ^{[8
]}

Tanguay, Jean-Francois ^{[9
]}

Windecker, Stephan ^{[10
]}

Garratt, Kirk N. ^{[11
]}

Kandzari, David E. ^{[12
]}

Lee, David P. ^{[13
]}

Simon, Daniel I. ^{[14
]}

Iancu, Adrian ^{[15
]}

Trebacz, Jaroslaw ^{[16
]}

Mauri, Laura ^{[17
]}

机构：

[1] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA

[2] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA

[3] Harvard Clin Res Inst, Boston, MA USA

[4] Harvard Clin Res Inst, Program Dev, Boston, MA USA

[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[6] Harvard Univ, Sch Med, Boston, MA USA

[7] Hop Bichat Claude Bernard, AP HP, Dept Cardiol, F-75877 Paris, France

[8] Univ Hosp Leicester Trust, Univ Hosp Leicester, Leicester Cardiovasc Biomed Res Unit, Glenfield Hosp,Natl Inst Hlth Res, Leicester, Leics, England

[9] Inst Cardiol Montreal, Montreal, PQ, Canada

[10] Univ Hosp Bern, CH-3010 Bern, Switzerland

[11] Lenox Hill Hosp, New York, NY 10021 USA

[12] Piedmont Heart Inst, Atlanta, GA USA

[13] Stanford Univ, Stanford, CA 94305 USA

[14] Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA

[15] Heart Inst N Stancioiu, Cluj Napoca, Romania

[16] Jan Pawel II Hosp Krakow, Krakow, Poland

[17] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA

来源：

CIRCULATION | 2014年 / 130卷 / 23期

关键词：

Antiplatelet drugs; Platelet receptor blockers; Percutaneous coronary intervention (PCI);

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2113 / 2113

页数：1

共 50 条

[1] Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents The Dual Antiplatelet Therapy Randomized Clinical Trial
Kereiakes, Dean J.
Yeh, Robert W.
Massaro, Joseph M.
Driscoll-Shempp, Priscilla
Cutlip, Donald E.
Steg, P. Gabriel
Gershlick, Anthony H.
Darius, Harald
Meredith, Ian T.
Ormiston, John
Tanguay, Jean Francois
Windecker, Stephan
Garratt, Kirk N.
Kandzari, David E.
Lee, David P.
Simon, Daniel I.
Iancu, Adrian Corneliu
Trebacz, Jaroslaw
Mauri, Laura
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (11): : 1113 - 1121
[2] Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
Kereiakes, Dean J.
Yeh, Robert W.
Massaro, Joseph M.
Driscoll-Shempp, Priscilla
Cutlip, Donald E.
Steg, P. Gabriel
Gershlick, Anthony H.
Darius, Harald
Meredith, Ian T.
Ormiston, John
Tanguay, Jean-Francois
Windecker, Stephan
Garratt, Kirk N.
Kandzari, David E.
Lee, David P.
Simon, Daniel I.
Iancu, Adrian Corneliu
Trebacz, Jaroslaw
Mauri, Laura
JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1552 - 1562
[3] Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents
Tomoda, Haruo
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14): : 1372 - 1373
[4] Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents REPLY
Mauri, Laura
Yeh, Robert W.
Kereiakes, Dean J.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14): : 1373 - 1374
[5] Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study
Mauri, Laura
Kereiakes, Dean J.
Yeh, Robert W.
Driscoll-Shempp, Priscilla
Cutlip, Donald E.
Steg, Philippe G.
Braunwald, Eugene
Wiviott, Stephen D.
Cohen, David J.
Holmes, David R., Jr.
Krucoff, Mitchell W.
Hermiller, James B.
Dauerman, Harold L.
Simon, Daniel I.
Kandzari, David E.
Garratt, Kirk N.
Lee, David P.
Pow, Thomas K.
Lee, Peter N. Ver
Rinaldi, Michael J.
Massaro, Joseph M.
CIRCULATION, 2014, 130 (23) : 2107 - 2107
[6] Dual Antiplatelet Therapy Duration in Patients With Drug-Eluting Stents
Bondar, Maria
Ilia, Mina
Fletcher, Hollie
US PHARMACIST, 2016, 41 (02) : HS2 - HS5
[7] Drug-eluting stents - Dual antiplatelet therapy for every survivor?
Bavry, Anthony A.
Bhatt, Deepak L.
CIRCULATION, 2007, 116 (07) : 696 - 699
[8] Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.
Park, Seung-Jung
Park, Duk-Woo
Kim, Young-Hak
Kang, Soo-Jin
Lee, Seung-Whan
Lee, Cheol Whan
Han, Ki-Hoon
Park, Seong-Wook
Yun, Sung-Cheol
Lee, Sang-Gon
Rha, Seung-Woon
Seong, In-Whan
Jeong, Myung-Ho
Hur, Seung-Ho
Lee, Nae-Hee
Yoon, Junghan
Yang, Joo-Young
Lee, Bong-Ki
Choi, Young-Jin
Chung, Wook-Sung
Lim, Do-Sun
Cheong, Sang-Sig
Kim, Kee-Sik
Chae, Jei Keon
Nah, Deuk-Young
Jeon, Doo-Soo
Seung, Ki Bae
Jang, Jae-Sik
Park, Hun Sik
Lee, Keun
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1374 - 1382
[9] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, Laura
Kereiakes, Dean J.
Yeh, Robert W.
Driscoll-Shempp, Priscilla
Cutlip, Donald E.
Steg, P. Gabriel
Normand, Sharon-Lise T.
Braunwald, Eugene
Wiviott, Stephen D.
Cohen, David J.
Holmes, David R., Jr.
Krucoff, Mitchell W.
Hermiller, James
Dauerman, Harold L.
Simon, Daniel I.
Kandzari, David E.
Garratt, Kirk N.
Lee, David P.
Pow, Thomas K.
Lee, Peter Ver
Rinaldi, Michael J.
Massaro, Joseph M.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23): : 2155 - 2166
[10] Dual antiplatelet therapy duration after drug-eluting stents: how long?
Helft, Gerard
JOURNAL OF THORACIC DISEASE, 2016, 8 (08) : E844 - E846

← 1 2 3 4 5 →